Anavex Life Sciences Corp (AVXL)

[F1ash]

Additionally, we will only be able to sell or issue to Lincoln Park 10,076,680 shares in total, which is equal to 19.99% of the shares of common stock outstanding on the date of the Purchase Agreement unless we obtain shareholder approval or the average price of such sales exceeds the price of our common stock on June 7, 2019 as determined under NASDAQ rules.



(2) The denominator is based on 58,664,946 shares outstanding as of April 27, 2020


On July 3, 2019, we filed the registration statement of which this prospectus supplement is a part, registering up to $250 million in securities utilizing a shelf registration process and on September 13, 2019 following the deregistration of all shares remaining registered under the 2016 Registration Statement, we filed a prospectus supplement to cover the issuance and sale of up to $15,514,532 of shares of our common stock. As of May 1, 2020 all of such shares have been sold and/or issued to Lincoln Park.